A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

PHASE3CompletedINTERVENTIONAL
Enrollment

1,297

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Infertility
Interventions
DRUG

DR-2011

Progesterone vaginal ring for approximately 10 weeks

DRUG

Crinone 8%

progesterone vaginal gel for approximately 10 weeks

Trial Locations (29)

20850

Duramed Investigational Site, Rockville

23507

Duramed Investigational Site, Norfolk

29201

Duramed Investigational Site, Columbia

29464

Duramed Investigational Site, Mt. Pleasant

29577

Duramed Investigational Site, Myrtle Beach

30005

Duramed Investigational Site, Alpharetta

30342

Duramed Investigational Site, Atlanta

33759

Duramed Investigational Site, Clearwater

43560

Duramed Investigational Site, Sylvania

45209

Duramed Investigational Site, Cincinnati

48126

Duramed Investigational Site, Dearborn

48197

Duramed Investigational Site, Ypsilanti

48307

Duramed Investigational Site, Rochester Hills

48503

Duramed Investigational Site, Flint

48604

Duramed Investigational Site, Saginaw

55125

Duramed Investigational Site, Woodbury

60035

Duramed Investigational Site, Highland Park

60610

Duramed Investigational Site, Chicago

76022

Duramed Investigational Site, Bedford

77598

Duramed Investigational Site, Webster

77706

Duramed Investigational Site, Beaumont

78731

Duramed Investigational Site, Austin

83702

Duramed Investigational Site, Boise

89511

Duramed Investigational Site, Reno

90064

Duramed Investigational Site, West Los Angeles

91356

Duramed Investigational Site, Tarzana

91361

Duramed Investigational Site, Westlake

08053

Duramed Investigational Site, Marlton

07960

Duramed Investigational Site, Morristown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duramed Research

INDUSTRY

NCT00615251 - A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization | Biotech Hunter | Biotech Hunter